Since tau has been recognized as an important actor in neurodegenerative diseases, many molecules that act on tau pathology have been investigated as potential vectors for therapeutic approaches for AD, but also for other tauopathies such as PSP or CBD. Here, MAPT is linked to supranuclear palsy, progressive, 1.